Global Anticoagulant Registry in the Field "GARFIELD-AF"


Phase N/A Results N/A

Summary of Purpose

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a pioneering real-world prospective registry - one of the largest in the field of non-valvular atrial fibrillation (AF). With an eventual enrolment target of 55,000 patients, GARFIELD-AF aims to enhance understanding of stroke prevention in patients with non-valvular AF worldwide and help in defining future treatment...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 December 2014.

1 Dec 2009 18 Mar 2010 1 Jul 2018 1 Jul 2018 1 Dec 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


See All